Médicos de Biópsia Testicular no exterior — Página 3

Dr. Abdullmutalip Simsek is a robotic and reconstructive urology specialist at Başakşehir Çam and Sakura Hospital. He is a member of the American Urological Association. He earned his PhD in reconstructive urology from the University of Sheffield, England. Dr. Simsek also holds membership in the European Association of Urology.

• Two-time recipient of the Alpay KELAMI award for Men's Sexual Health.
• Performs robotic prostatectomy and complex bladder removal with reconstruction.
• Specializes in penile curvature correction and artificial urinary sphincter implantation.
• Member of the American Society of Genitourinary Reconstructive Surgery.

O médico é especializado em cirurgia colorretal, pancreática e gastrointestinal, com uma expertise particular em procedimentos de Whipple. Com mais de 45 anos de prática, o médico é reconhecido como um dos principais cirurgiões de Whipple em Israel.<\/p>

Dr. Yusuf Acikgoz is a medical oncologist at Lokman Hekim University Ankara Hospital. He specializes in treating complex cancers, including lung, breast, and liver malignancies. He completed a fellowship at Ohio State University in the United States. Dr. Acikgoz manages treatments like chemotherapy, radioembolization, and immunotherapy.

• Member of the American Society of Clinical Oncology (ASCO).
• Assistant Investigator for Phase III clinical trials, including the CheckMate-649 study.
• Certified in Good Clinical Practice and Human Subjects Protection at Ohio State University.
• Performs diagnostic procedures like biopsy, gastroscopy, and tumor marker testing.

Dr. Oguzhan Parlak is a urological surgeon at Valued Med Hub Hospitals in Istanbul. He specializes in andrology, endourology, and uro-oncology. Dr. Parlak performs robotic da Vinci prostatectomies and kidney-sparing surgeries. He treats both adults and children for complex urological conditions.

• Performs flexible ureterorenoscopy and holmium laser enucleation of the prostate.
• Treats conditions ranging from kidney cysts to prostatic hyperplasia.
• Expertise in hydroselectomy, varicocelectomy, and urethral reconstruction.
• Works at a clinic holding an International Health Tourism Authorization Certificate.

Dr. Murat Zor is a urologist at Liv Bona Dea Hospital Baku. He specializes in robotic urology, urooncology, and laser prostate surgeries like HoLEP. He received the Turkish Association of Urology’s Best Paper Award. Dr. Zor treats kidney stones, prostate cancer, and male infertility issues including azoospermia.

• Performs robotic da Vinci prostatectomy and Holmium Laser Enucleation of the Prostate.
• Expert in MRI transrectal and transperineal ultrasonography prostate fusion biopsies.
• Member of the American Urological Association and European Association of Urology.
• Works at a JCI-accredited hospital with 100% safety compliance.

O médico é um especialista renomado no Centro Médico Sourasky, focando na circuncisão no exterior, tratamento de cálculos renais, prostatectomia, ressecção transuretral da próstata (RTUP), consulta de urologia e vasectomia no exterior.<\/p>

Oferecendo tratamentos abrangentes para várias condições urológicas, o médico é dedicado a ajudar os pacientes a retornarem a uma vida saudável.<\/p>

O médico é um distinto oncologista médico e internista austríaco com mais de duas décadas de experiência, especializado em câncer de mama, malignidades ginecológicas e terapias direcionadas contra o câncer. Graduado pela Universidade de Viena, o médico completou residência em medicina interna e oncologia médica na Universidade Médica de Viena. O médico contribuiu para os primeiros ensaios clínicos sobre terapias direcionadas e é uma autoridade líder no tratamento individualizado do câncer.<\/p>

Atualmente atuando como consultor sênior no Wiener Privatklinik e continuando o trabalho acadêmico na Universidade Médica de Viena, o médico foca na terapia sistêmica individualizada do câncer, imunoterapia e pesquisa oncológica translacional. A pesquisa do médico inclui o desenvolvimento de biomarcadores e mecanismos de resistência a medicamentos direcionados, com publicações em revistas internacionais de destaque.<\/p>

O médico é um especialista renomado em onco-urologia, urologia e cirurgia, liderando o Departamento de Urologia no Centro Médico Sourasky. Especializando-se no tratamento de doenças genito-urinárias, incluindo tumores malignos, o médico é uma autoridade em braquiterapia e crioterapia, focando em irradiação direcionada e tratamentos de baixa temperatura para células tumorais.<\/p>

O médico é membro da Associação Médica de Israel e da Associação de Urologistas na Europa, nos EUA e em Israel.<\/p>

O médico é um cirurgião certificado com ampla experiência em cirurgia minimamente invasiva e robótica. Especializando-se nessas técnicas cirúrgicas avançadas, o médico pratica no Centro Médico Sourasky, onde aplica sua expertise para melhorar os resultados dos pacientes.<\/p>

Dra. Viola Fox é a Médica Chefe da Clínica de Hematologia, Oncologia e Medicina Paliativa no BKZ Solingen. Esta clínica é um centro de câncer interdisciplinar certificado. A Dra. Fox é uma especialista de destaque em terapia medicamentosa para doenças tumorais na Alemanha e na Europa. Ela tem mais de 15 anos de experiência nesta área.

Ela é membro da Sociedade Alemã de Oncologia e Hemato-oncologia (GDHO), da Associação Alemã de Médicos e da American Association for Cancer Research. A Dra. Fox também é ativa na pesquisa em biologia molecular. Seu trabalho apoia o progresso no tratamento do câncer e nos diagnósticos moleculares.

As suas principais áreas de especialização são a quimioterapia, a imunoterapia, a terapia alvo e a radioterapia. A Dra. Fox é conhecida por seus métodos inovadores e forte compromisso com o cuidado ao paciente. Seus esforços levaram a altas taxas de recuperação e reconhecimento de seus pares.

Dr. Cevper Ersoz is a urologist at Medipol Acibadem District Hospital in Istanbul. He specializes in robotic and laparoscopic surgery for urological cancers. Dr. Ersoz is a Fellow of the European Board of Urology (FEBU). He completed an observership in urologic surgery at the University of Michigan, USA.

• Author of over 130 national and international peer-reviewed scientific publications.
• Treats benign prostate hyperplasia using HoLEP, TuLEP, and Rezum techniques.
• Performs minimally invasive procedures for stone diseases, including PCNL and URS.
• Practices at JCI-accredited Medipol Acibadem, which uses the da Vinci robotic system.

Dr. Ozgur Haki Yuksel is a urology specialist at VM Medical Park Pendik Hospital. He holds FEBU Board Certification, recognized across Europe for excellence in urology. Dr. Yuksel completed observership training at the University of Michigan in the United States. He teaches as a faculty member at Bahcesehir University.

• Specializes in robotic and laparoscopic surgery for urological oncology.
• Treats complex conditions like stone diseases, male infertility, and urinary incontinence.
• Authored over 45 national and international medical publications.
• Member of the European Urology Association and the Turkish Urology Association.

Dr. Cemil Bilir is a professor of medical oncology at VM Medical Park Pendik Hospital in Istanbul. He specializes in immunotherapy and chemotherapy for lung, breast, and prostate cancers. A former research fellow at Northeastern University in Boston, he focused on pharmaceutical biotechnology and nanomedicine. Dr. Bilir works at a JCI-accredited facility where academic physicians provide around-the-clock care.

• Member of the American Society of Clinical Oncology (ASCO) and ESMO.
• Completed a specialized clinical rotation at the Cleveland Clinic in the U.S.
• Treats complex oncological cases, including stage 4 lung cancer and sarcoma.
• Current Ph.D. student in inorganic chemistry at Sakarya University.

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Navarro Vilches leads the Urology Unit at Quirónsalud Marbella Hospital. He specializes in male reproductive health and lower urinary tract surgery. Dr. Vilches completed a study stay at the Memorial Sloan-Kettering Cancer Center in New York. He is a co-founder of the Urologic Surgery Institute of Malaga.

• Expert in renal surgery and robotic da Vinci prostatectomy.
• Former member of the Renal Transplant Unit at Carlos Haya Hospital.
• Treats conditions including BPH, varicocele, and Peyronie's disease.
• Works at JCI-accredited Quirónsalud Marbella, part of Spain's largest private hospital group.

Dr. Ercan Ozden is a medical oncologist and internal medicine specialist at VM Medical Park Pendik. He provides treatment for a wide range of cancers, including breast, lung, and colon cancer. Dr. Ozden trained at Istanbul University, Cerrahpasa Faculty of Medicine. He later completed a medical oncology subspecialty at Kocaeli University.

• Specializes in immunotherapy, target therapy, and chemotherapy for complex cases.
• Treats patients at a JCI-accredited hospital in Istanbul.
• Performs staging and biopsies for liver, lung, and pancreatic tumors.
• Provides targeted immunotherapy using medications like Keytruda.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.